Min He

1.6k citations
63 papers · 1.0k indexed · h-index 19
Topics
Pituitary Gland Disorders and Treatments (27 papers)Growth Hormone and Insulin-like Growth Factors (20 papers)Adrenal and Paraganglionic Tumors (8 papers)
Partner nations
ChinaUnited StatesSweden

In The Last Decade

Min He

59 papers receiving 1.0k citations

Peers

Min He
Comparison fields: 5 of 108
  • Endocrinology, Diabetes and Metabolism 407
  • Molecular Biology 243
  • Surgery 242
  • Epidemiology 231
  • Cardiology and Cardiovascular Medicine 176
Replace Dariusz Moczulski with:
Dariusz Moczulski Poland
Hideaki Nakatsuji Japan
Lianxi Li China
Jingtao Dou China
Angela Barini Italy
Guangda Xiang China
Müjde Aktürk Türkiye
Florian M.M. Baeres Denmark
Tetsuyuki Yasuda Japan
Grażyna Bednarek-Tupikowska Poland
Min He relative to Dariusz Moczulski Poland Dariusz Moczulski's profile →
Citations per field
00.5×4.5×
Dariusz Moczulski · 1×
Citations per year

Countries citing papers authored by Min He

Since Specialization
Citations

This map shows the geographic impact of Min He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min He more than expected).

Fields of papers citing papers by Min He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min He. The network helps show where Min He may publish in the future.

Co-authorship network of co-authors of Min He

This figure shows the co-authorship network connecting the top 25 collaborators of Min He. A scholar is included among the top collaborators of Min He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min He. Min He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 9
5 6
6 6
7 7
8 13
9 10
10 10
11 8
12 9
13 6
14 15
15 17
16 13
17 47
18 1
19 69
20 107

About Min He

Min He is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine, having authored 63 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (27 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Adrenal and Paraganglionic Tumors (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (407 citations), Nephrology (127 citations) and Cardiology and Cardiovascular Medicine (176 citations). Min He has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Zhaoyun Zhang, Renming Hu, Bin Lü, Shen Qu, Lili Chen, Ying Huang, Yiming Li, Jie Wen, Hongying Ye and Weiwei Zhang. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026